medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number S1

<< Back Next >>

Med Cutan Iber Lat Am 2015; 43 (S1)

Acrodermatitis chronica atrophicans: a case report and review of the literature

da Hora NCM, Reis SC, Castro BRVM, Tadeu VR, Bedin V
Full text How to cite this article

Language: Portugu?s
References: 13
Page: 28-31
PDF size: 232.09 Kb.


Key words:

Acrodermatitis chronica atrophicans, Lyme, borreliosis, ceftriaxone, facial palsy.

ABSTRACT

The acrodermatitis chronica atrophicans (ACA) is a cutaneous manifestation of Lyme disease in its late phase, caused by the spirochete Borrelia burgdorferi sensu lato and has varied clinical manifestations, and the main affected organs are: skin, joints, central nervous system (CNS) and heart. It has, like syphilis, recent and late phases, both of which can be localized or disseminated, especially erythema chronicum migrans, limphocytoma cutis, conjunctivitis, cranial nerve neuritis, encephalitis, pancarditis, arthralgia, myalgia and ACA. The authors report a case of acrodermatitis chronica atrophicans in a patient of 53 years with skin lesions of the lower limbs consistent with ACA, and other clinical findings of Lyme disease, with prior treatment for various clinical manifestations independently, without a diagnosis.


REFERENCES

  1. Hytönen J, Hartiala P, Oksi J, Viljanen MK. Borreliosis: recent research, diagnosis, and management. Scand J Rheumatol. 2008; 37: 161-172.

  2. Burgdorfer W, Barbour AG, Hayes SF et al. Lyme disease – a tick- borne spirochetosis? Science. 1982; 216: 1317-1319.

  3. Bratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD. Diagnosis and treatment of Lyme Disease. Mayo Clin Proc. 2008; 83 (5): 566-571.

  4. Marques AR. Lyme disease: a review. Curr Allergy Asthma Rep. 2010; 10: 13-20.

  5. Nau R, Christen H-J, Eiffert H. Lyme disease: current state of knowledge. Dtsch Arztebl Int. 2009; 106 (5): 72-82.

  6. Steere AC. Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut. Wien Klin Wochenschr. 2006; 118/21-22: 625-633.

  7. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis. 2003; 3: 489-500.

  8. Stanek G, Strle F. Lyme borreliosis: a European perspective on diagnosis and clinical management. Curr Opin Infect Dis. 2009; 22: 450-454.

  9. Hoppa E, Bachur R. Lyme disease update. Curr Opin Pediatr. 2007; 19: 275-280.

  10. Walsh CA, Mayer EW, Baxi LV. Lyme disease in pregnancy: case report and review of the literature. Obstet Gynecol Surv. 2006; 62 (1): 41-50.

  11. Marques A. Chronic lyme disease: an appraisal. Infect Dis Clin North Am. 2008; 22 (2): 341-360.

  12. Fonseca AH, Salles RS, Salles SAN, Madureira RC, Yoshinari NH. Borreliose de Lyme simile: uma doença emergente e relevante para a dermatologia no Brasil. An Bras Dermatol. 2005; 80 (2): 171-178.

  13. Santos M, Haddad Jr V, Ribeiro-Rodrigues R, Talhari S. Borreliose de Lyme. An Bras Dermatol. 2010; 85 (6): 930-938.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2015;43